Maximizing use of existing carcinogenicity data to support acceptable intake levels for mutagenic impurities in pharmaceuticals: Learnings from N-nitrosamine case studies
Susan P. Felter, David J. Ponting, Ashley M Mudd, Robert Thomas, Andréa Alice da Fonseca Oliveira
Topics & Concepts
CarcinogenEconomic shortageBiochemical engineeringDrugChemistryToxicologyRisk analysis (engineering)BusinessPharmacologyMedicineBiologyOrganic chemistryEngineeringPhilosophyLinguisticsGovernment (linguistics)Carcinogens and Genotoxicity AssessmentPharmaceutical and Antibiotic Environmental ImpactsWater Treatment and Disinfection